Title |
Year |
Author |
Number |
SIDE CHAIN TAXANES, INTERMEDIATE COMPOUNDS, AND METHODS OR PREPARING, THEREOF |
1993 |
- Mikaehl A.Poss
- Dehvid Dzh.Kusera
- Dzherom L.Moniot
- Dzhon K.Tottatil
- Ivan D.Trifunovich
- Shu-Kh'Ju Chen
- Dzhanmej Vej
|
RU2125042C1 |
BIPHENYLISOXAZOLSULFONAMIDES |
1995 |
- Nejtsen M'Jurudzhsan
- Dzhoel S. Berrish
|
RU2174979C2 |
6,7-MODIFIED PACLITAXELS AND INTERMEDIATE COMPOUNDS |
1993 |
- Shu-Kh'Ju Chen
- Vittorio Farina
- Gregori Rot
- Dzhon Kehdou
|
RU2125998C1 |
SUBSTITUTED BIPHENYLSULFONAMIDES, PHARMACEUTICAL COMPOSITION BASED ON THESE COMPOUNDS, AND METHOD FOR ANTAGONISTIC ACTION OF ENDOTHELIN |
1996 |
- Nehtesehn Murugesehn
- Dzhoel K. Behrrish
- Filip D. Stejn
|
RU2159770C2 |
DERIVATIVES OF N-ACYL-2-ARYLCYCLOALKYLAMINE STIMULATING MELATONIN SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF MELATONIN-STIMULATING BINDING |
1996 |
- Dehniel Dzh. Kivi
- Majkl F. Parker
- Ronal'D Dzh. Mehttson
- Grehkham Dzhonson
|
RU2162076C2 |
4-PYRIMIDINE- OR PYRIDINYL DERIVATIVES OF INDOLE-3-YL-ALKYLPIPERAZINES, PHARMACEUTICAL COMPOSITION |
1992 |
- Dehvid V.Smit
- Frehnk D.Vokka
- Dzhozef P.Evich
- Ronal'D Dzh.Mattson
- Ehndrju Uil'Jams
- Ehdvard Kh.Rudiger
- Kejt Din Kombrink
- Brehdli Klajd Pirs
|
RU2114111C1 |
TAXANE DERIVATIVE PHOSPHONOOXYMETHYL ESTERS, INTERMEDIATE COMPOUNDS, ANTITUMOR PHARMACEUTICAL COMPOSITION, METHOD OF TUMOR GROWTH SUPPRESSION IN MAMMALS |
1993 |
- Erzhi Golik
- Dolatraj Vias
- Dzhon Dzh. Rajt
- Genri Vong
- Dzhon F.Kadou
- Dzhon K.Totatil
- Ven-Sen Li
- Murrej A.Kaplan
- Robert K.Perron
|
RU2136673C1 |
RETINOID-LIKE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1996 |
- Dzhon E. Stehrrehtt Ml.
- Kuo-Long Ju.
- Muzammil M. Mansuri
- Dehvid R. Tortolani
- Peter R. Rezhek
|
RU2163590C2 |
1,2,5-THIADIAZOLE DERIVATIVES OF INDOLYLALKYL-PYRIMIDINYL-PIPERAZINES AND PHARMACEUTICAL COMPOSITION BASED ON THESE COMPOUNDS |
1996 |
- Ronni R. Krenshou
- Ehdvard Kh. Rudiger
- Dehvid V. Smit
- Karola Solomon
- Dzhozef Jevich
|
RU2165420C2 |
SULFAMIDE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHOD OF INHIBITION OF ET RECEPTORS |
1994 |
|
RU2141953C1 |